Every SEC Form 3/4/5 on record for this filer (CIK 1197018) — 5 issuers, 115 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | Director | 2017-01-31 → 2026-01-06 | 17 | −$21M |
| CERE | Cerevel Therapeutics Holdings, Inc. | Director | 2020-10-30 → 2024-08-05 | 26 | −$30M |
| YMTX | YUMANITY THERAPEUTICS, INC. | Executive Chair · Director · lapsed | 2020-12-28 → 2021-04-02 | 4 | — |
| MCK | MCKESSON CORP | Director · lapsed | 2015-07-31 → 2020-08-19 | 8 | −$558,288 |
| CRSP | CRISPR Therapeutics AG | Director · lapsed | 2016-10-18 → 2017-06-02 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CERE | 2024-07-01 | Sell | 25,000 | $41.18 | $1M | 25,928 |
| CERE | 2024-06-03 | Sell | 50,000 | $40.61 | $2M | 15,638 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
